Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis

Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, University of Western Ontario, London, Canada.
Stroke (Impact Factor: 6.02). 12/2005; 36(11):2373-8. DOI: 10.1161/01.STR.0000185922.49809.46
Source: PubMed

ABSTRACT Carotid endarterectomy clearly benefits patients with symptomatic severe stenosis (SCS), but the risk of stroke is so low for asymptomatic patients (ACS) that the number needed to treat is very high. We studied transcranial Doppler (TCD) embolus detection as a method for identifying patients at higher risk who would have a lower number needed to treat.
Patients with carotid stenosis of > or =60% by Doppler ultrasound who had never been symptomatic (81%) or had been asymptomatic for at least 18 months (19%) were studied with TCD embolus detection for up to 1 hour on 2 occasions a week apart; patients were followed for 2 years.
319 patients were studied, age (standard deviation) 69.68 (9.12) years; 32 (10%) had microemboli at baseline (TCD+). Events were more likely to occur in the first year. Patients with microemboli were much more likely to have microemboli 1 year later (34.4 versus 1.4%; P<0.0001) and were more likely to have a stroke during the first year of follow-up (15.6%, 95% CI, 4.1 to 79; versus 1%, 95% CI, 1.01 to 1.36; P<0.0001).
Our findings indicate that TCD- ACS will not benefit from endarterectomy or stenting unless it can be done with a risk <1%; TCD+ may benefit as much as SCS if their surgical risk is not higher. These findings suggest that ACS should be managed medically with delay of surgery or stenting until the occurrence of symptoms or emboli.

Download full-text


Available from: J. David Spence, Jun 29, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Transcranial Ultrasound (TCD) is a neurosonological procedure to examine intracranial brain supplying arteries, by visualizing cerebral blood flow patterns. In patients suffering from severe blood flow disruption to the brain neurological pathology conditions such as stenosis, occlusions and vasospasm can be identified with TCD. Ischemic and hemorrhagic strokes require regular TCD monitoring. However, the TCD procedure is largely dependent on the operator's skills and experiences. Finding a suitable site on the temporal plane (an acoustic window) for transcranial insonoification can be challenging in patients with poor or no acoustic windows. In such cases, diagnosis and prognosis may be problematic. Approximately, 10-20% of patients have poor or no acoustic windows. Therefore, early detection of acoustic windows for transcranial sonograph is desirable. This paper examines ultrasound signals in-vitro bovine's biological transcranial media to early detect acoustic windows. The results suggest that transcranial acoustic windows can be detected with an ultrasound signal. Ultrasound attenuation-velocity and B-Mode Ultrasound detection contrast the temporal bone and the surrounding soft-tissue, suggesting that acoustic windows can be detected.
  • [Show abstract] [Hide abstract]
    ABSTRACT: A new embolus detection system (EDS) is presented, built with the intention of detecting ongoing cerebral embolization in patients at risk of transient ischaemic attacks or stroke. It is based on the analysis of the audio-Doppler signal of a transcranial Doppler machine. The algorithm of the EDS estimates the intensity, duration and zero-crossing dynamics of the audio signal. The EDS has a multi-layer neural network which classifies events into micro-emboli signals (MES) or artefacts. The decision-making component of the software has been validated against human experts. Data from patients in the post-operative phase of carotid surgery were used for the validation process. The results showed agreement in MES and artefact classification of > 93%. Apart from a monitoring display, the monitoring system includes a verification unit that allows the user to listen and to look at all data of individual MES and artefacts. Moreover, the system allows the user to record, store and re-calculate all data files. Data are stored using European Data Format, which allows data transportation over the Internet. The EDS may have a potential in stroke risk stratification, evaluating the effect of novel anti-thrombotic therapies, and in peri-operative and remote monitoring of carotid endarterectomy.
    Journal of Medical Engineering & Technology 32(4):296-304. DOI:10.1080/03091900701541265
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Myeloproliferative Syndrome (MPS) gehen mit einem erhöhten Thromboembolierisiko einher. Ziel dieser Studie war es, den prognostischen Wert der Mikroemboliedetektion hinsichtlich des Auftretens klinischer Ereignisse zu untersuchen sowie zu prüfen ob es zwischen den detektierten Mikroembolien, Parametern des Blutbildes und den Ergebnissen der Thrombozyten–Durchflusszytometrie einen Zusammenhang gibt, aus dem sich Rückschlüsse auf die Zusammensetzung zirkulierender Mikroembolien (Microembolic signals, MES) bei diesen Patienten ziehen lassen. Untersucht wurden 42 Patienten mit myeloproliferativen Syndromen. Bei allen Patienten erfolgte einmalig eine trankranielle Doppleruntersuchung mit Mikroemboliedetektion sowie eine Blutbilduntersuchung am Tag der Doppleruntersuchung. Die Ergebnisse wurden mit dem Auftreten klinischer Ereinisse über einen Beobachtungszeitraum von 29,7+/-7,3 Monate korreliert. Bei 17 Patienten erfolgte zusätzlich eine durchflusszytometrische Untersuchung. Bei 15 von 42 Patienten (35,7%)wurden MES registriert, es konnte jedoch kein Zusammenhang mit dem MPS-Typ, den Parametern des Blutbilds oder dem Auftreten von thromboembolischen Ereignissen hergestellt werden. MES-positive und -negative Patienten unterschieden sich auch nicht hinsichtlich der Verteilung von aktivierten Thrombozyten, Thrombozyten-Mikroaggregaten oder Mikropartikeln. Es zeigte sich jedoch ein starker Trend für das vermehrte Auftreten von Thrombozyten-Neutrophilen-Aggregaten bei MES-positiven Patienten (p = 0,09). Insgesamt zeigte sich, dass die einmalige trankranielle Emboliedetektion bei Patienten mit MPS keinen prognostischen Wert besitzt. Die Ergebnisse der Durchflusszytometrie lassen jedoch vermuten dass MES bei MPS-Patienten aus Thrombozyten-Neutrophilen-Aggregaten bestehen könnten. Myeloproliferative disorders (MPD) are associated with an increased risk for thrombembolic events. In this study we examined the prognostic value of transcranial doppler (TCD) microemboli detection regarding clinical events and correlated TCD findings with results of blood cell counts and platelet flow cytometry to gain insight into the composition of circulating microemboli in these patients. In a cohort of 42 patients with MPD TCD microemboli detection was performed on a single occasion and correlated with thrombembolic events during a prospective follow-up of 29.7 +/- 7.3 months. In all patients a complete blood cell count and in 17 patients platelet flow cytometry were performed on the day of the TCD examination. Microembolic signals (MES) were recorded in 15 (35.7%) patients, however, without any correlation with the type of MPD, blood cell count, or thrombembolic events. MES positive and negative patients did not differ regarding the levels of activated platelets, platelet microaggregates, or microparticles. We found a strong trend for higher rates of platelet-neutrophil conjugates in MES positive patients (p = 0.09). In conclusion we found that detection of MES by TCD in MPD patients on a single occasion has no prognostic value. MES do not correlate with the type of MPD, nor blood cell counts or clinical events. Flow cytometry suggests that MES in MPD may primarily consist of platelet-neutrophil aggregates.